No Data
No Data
Asia vets Future (NASDAQ: AIFU): Reshaping the AI insurance and big health industry, can the future be expected?
Hong Kong, November 29, 2024 /PRNewswire/ -- Asia Vets Future Limited (NASDAQ: AIFU), a leading company focusing on insurance agency and claims services. Recently, the company has been gradually promoting its transformation towards intelligence and diversification, aiming to seize the potential growth opportunities in AI insurance and the big health sector. The restructuring of its high-quality assets and strategic cooperation with Bohme Group (NASDAQ: BGM) are expected to create a second curve of future performance growth for the company. 1. Restructure high-quality assets to create a smarter future, AIFU recently restructured its core assets, involving an amount of
Yunnan Baiyao Group (000538.SZ) plans to invest 5 billion yuan in the traditional chinese medicine health innovation fund.
Yunnan Baiyao Group (000538.SZ) announced that the company plans to jointly invest with ICBC International to establish Yunnan Province Traditional Chinese Medicine University...
Yixintang Pharmaceutical (002727.SZ): Sichuan Yixintang plans to invest 0.368 billion yuan to construct the large health intelligent pharmaceutical base logistics center project.
On November 26, Gelonghui reported that yixintang pharmaceutical (002727.SZ) announced that, according to the company's global strategy and business positioning, to enhance the company's logistics delivery capacity within Sichuan Province and meet future development needs, the company has agreed that its wholly-owned subsidiary yixintang pharmaceutical (Sichuan) Co., Ltd. (hereinafter referred to as "Sichuan yixintang") will invest 0.368 billion yuan to construct a logistics center project for the health and intelligent pharmaceutical base in Chengdu, Sichuan Province. The new logistics center is expected to meet the business development needs of the company in the Sichuan-Chongqing region.
Universal Health International Unit Buys Stake in Hollow Capsule Manufacturer
Uni health (02211.HK) plans to sell a 43.78% stake in jilin Jintian Uni Health Group for 43 million yuan.
Grain Hall November 19th | Uni Health International (02211.HK) announced that on November 19, 2024, the seller (Heilongjiang Jintian Love Pharmaceutical Distribution Co., Ltd.) (an indirect wholly-owned subsidiary of the company), entered into an equity transfer agreement with the buyer (Huang Yanling). According to this, the seller has conditionally agreed to sell, and the buyer has conditionally agreed to acquire 43.78% equity of Jilin Jintian Uni Health Capsule Co., Ltd., for RMB 43 million, subject to the restrictions of the equity transfer agreement. After the completion of the sale, the company will no longer hold any equity in the target company. Target Public
Express News | Universal Health International - Unit to Sell 43.78% Stake in Jilin Jintian Universal Health Group Capsules for RMB43.0 Mln
No Data
No Data